Influence of Sodium Intake in spondyLoarthriTes
Recruiting · NCT06259890 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire de Besancon
View the official record on ClinicalTrials.gov →Interventions studied
measurement of salt intake
What this trial is about
The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
- women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)
Exclusion criteria
- patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
- current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
- patients on systemic corticosteroids with corticosteroid therapy \> 10 mg prednisone equivalent
- pregnant woman
Where it is running
4 locations listed.
- CHU Besançon - Besançon, France
- CHD Vendée - La Roche-sur-Yon, France
- CHU St Etienne - Saint-Etienne, France
- Hôpital Nord Franche-Comté - Trévenans, France